CMAC National Facility
Advanced capability for translational medicines manufacturing
Located within the University of Strathclyde, CMAC’s National Facility is a purpose-built 900m2 environment providing access to future-ready technologies, specialist expertise, and integrated digital systems.
A DIFFERENT KIND OF RESEARCH PARTNER
WHO WE ARE
CMAC is a publicly funded national research centre, not a contract research organisation. When you work with us, you're accessing a multidisciplinary scientific community that will help you understand why your process behaves the way it does, and how to design it better from the outset.
WHO WE WORK WITH
We collaborate with organisations of all sizes, academic institutions, technology developers and innovation partners.
OUR APPROACH
We deliver agile, data‑driven solutions through advanced facilities, integrated digital tools and specialist expertise, providing flexible, end‑to‑end support that accelerates high‑quality, efficient medicines development.
Transforming medicines development from molecule to market
We deliver agile, data-driven R&D supporting discovery, particle engineering, crystallisation, formulation development, continuous drug product manufacturing and advanced analytics. Our approach integrates digital CMC principles - real-time data capture, model-informed development, AI/ML tools, and connected knowledge graph infrastructure.
End-to-end capability
Taking continuous manufacturing from synthesis to final form - reducing cycle times, improving consistency and enabling real-time quality control.
ENGAGEMENT PATHWAYS
Full project delivery
End-to-end R&D for complex pharmaceutical development challenges.
Digital-enabled research
Our digital CMC infrastructure is designed to make your results more valuable over time: structured, connected and ready to power AI-enabled pharmaceutical development.
Open access facility use
Hands-on use of our technology platforms with expert technical support.
Technical and digital characterisation
Targeted analytical, modelling and process-design grounded in digital CMC, enabling predictive control and accelerated process understanding.
Technical consultancy and one-off services
Targeted analytics, modelling, troubleshooting and specialist expertise on demand.
RESEARCH AND CONSULTANCY SERVICES
Our services span the full development pipeline
X-Ray Diffraction and Solid State Characterisation
Comprehensive structural characterisation solutions for pharmaceutical and advanced materials development.
Crystallisation
Rapid, model-informed process development - reliable control of particle size, polymorph and yield.
Analytics
Contact us to learn about our analytical capabilities.
Drug Product
30+ validated predictive modelling tools and expertise across secondary manufacturing for faster, more confident decisions.
Nanomedicine
Contact us to learn about our nanomedicine capabilities.
Don’t see what you need?
WHY WORK WITH CMAC
The case for partnership
End-to-end support
Integrated services across drug substance, drug product and analytics under one roof
Proven track record
A strong history of solving complex industrial challenges with pharmaceutical partners
Industry-aligned research
Co-created with global pharmaceutical partners, directly aligned to real manufacturing challenges
Multidisciplinary expertise
Chemistry, pharmaceutics, engineering, analytics, and modelling experts, working as one team
Accelerated development
Streamlined, data-driven workflows and digital tools get you to market faster with fewer experiments
Flexible access
Engage with us on your terms - full project delivery, technical consultancy, or one-off support
FROM OUR PARTNERS
Discovery to Particle Engineering:
“CMAC’s particle engineering support accelerated our API readiness, giving us material suitable for continuous processing far earlier than expected.”
— Former CustomerFormulation & Continuous Processing:
“The continuous direct compression expertise at CMAC significantly improved our material performance and reduced development cycle times.”
— Former CustomerDigital CMC & Analytics:
“The digital workflows and model‑informed approaches helped us identify optimal operating conditions with far fewer experiments.”
— Former Customer